Leo James' Lab retweeted
Postdoc position in dendritic cell and cross-presentation biology - four days left to apply:
mrc.tal.net/vx/mobile-0/appc…
Join our team to work on these coolest cells ever! 🥰
Leo James' Lab retweeted
Join the RNA Virus Replication Lab @TheCrick, Europe's largest biomedical institute under 1 roof!
🔴 TWO postdocs (4-6yrs)
🔴 ONE PhD student (4yrs, fully funded, all🌍)
We’re looking for bright, motivated people, with the chance to develop & shape projects independently... 1/n
Leo James' Lab retweeted
Researchers at @UKDRI and @MRC_LMB have developed two novel therapies that target tau aggregates in the brain and have shown promise in treating dementia in mice
@w_mcewan @JamesLab9 biotechniques.com/proteomics…
Leo James' Lab retweeted
Scientists have developed potential therapies that selectively remove aggregated tau proteins and improve symptoms of neurodegeneration in mice, showing a promising approach for Alzheimer’s disease.
More: orlo.uk/N50dm @UKDRI @MRC_LMB
@donna_mallery is on her way and she will present this new study from our lab:
xitter.cf/JamesLab9/status/18359…
New study from the lab! Charged rings in the mature HIV capsid protein are required for formation of conical capsids: nature.com/articles/s41467-0…
Thanks to all authors of that study: @AlexKleinpeter @donna_mallery Nadine Renner, @AnnaAlbecka and Ole Klarhof. Great collaboration between our lab @MRC_LMB and Eric Freed's lab @NIH
In forced evolution experiments we identified K25A compensating mutations that restore hexamer/pentamer ratio and rescue the shape of the capsid
Mutations in charged ring residues R18 and K25 lead to formation of circular or tubular capsids in vitro. These mutant viruses are also not infectious in cell culture.
Right number of capsid protein hexamers and pentamers is required for formation of conical shaped capsids
New study from the lab! Charged rings in the mature HIV capsid protein are required for formation of conical capsids: nature.com/articles/s41467-0…
We are looking for a PhD student to continue our exciting work on antiviral immune receptor Trim21! Contact us for any questions and apply here:
This quoted post is unavailable.
Leo James' Lab retweeted
The UK DRI's @w_mcewan & @JamesLab9 (@MRC_LMB) have developed new therapies that selectively remove aggregated tau proteins - harnessing the unique capabilities of a protein called TRIM21.
The treatment improved symptoms of neurodegeneration in mice👉buff.ly/47ogpFG
Leo James' Lab retweeted
New research from @JamesLab9 & colleagues presents 'RING-Bait', which employs an aggregating protein sequence combined with an E3 ubiquitin ligase to specifically degrade tau aggregates while sparing soluble tau (in vitro & in vivo) - impressive new tech!
cell.com/cell/fulltext/S0092…
Amazing new study from the lab on targeted tau degradation technology:
Super excited to share our latest paper on a novel targeted protein degradation technology, now out in @CellCellPress. We introduce RING-Bait technology, an innovative approach to selectively target and degrade intracellular protein aggregates (1/7) cell.com/cell/fulltext/S0092…
Our recent contribution to work from Gabriella Santoro's lab with @AnnaAlbecka SARS-CoV-2 experiments. Check it out! @SS_Silvia88 @guipap_ @MRC_LMB link.springer.com/article/10…
Great to be in Leeds for #BUNYA2024 conference! The lab is new to #bunyaviruses so we are sure to learn a lot!
Congratulations to @MatteoAll and @LabSchafer! And well done to us!
This quoted post is unavailable.
If you are at #ubfriends2024 don't miss Jakub Luptak's talk about the role of E2 enzymes in TRIM21 driven ubiquitination. Friday at 11.45. New, exciting data from the lab for ubiquitin enthusiasts 😉

















